BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20485251)

  • 1. New therapies for gastroesophageal reflux disease.
    Bredenoord AJ
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):129-38. PubMed ID: 20485251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
    Watson TJ; Peters JH
    Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.
    Johnson DA; Levy BH
    Expert Opin Pharmacother; 2010 Jun; 11(9):1541-8. PubMed ID: 20450445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of gastro-esophageal reflux disease: the new kids to block.
    Blondeau K
    Neurogastroenterol Motil; 2010 Aug; 22(8):836-40. PubMed ID: 20663054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reflux inhibitors: a new approach for GERD?
    Boeckxstaens GE
    Curr Opin Pharmacol; 2008 Dec; 8(6):685-9. PubMed ID: 18771751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in endoscopic antireflux techniques.
    Vassiliou MC; von Renteln D; Rothstein RI
    Gastrointest Endosc Clin N Am; 2010 Jan; 20(1):89-101, vii. PubMed ID: 19951796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease.
    Tack J
    Curr Opin Gastroenterol; 2005 Jul; 21(4):454-60. PubMed ID: 15930988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?
    Beaumont H; Boeckxstaens GE
    Am J Gastroenterol; 2009 Jul; 104(7):1764-71. PubMed ID: 19491837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging drugs for gastroesophageal reflux disease.
    Boeckxstaens GE
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):481-91. PubMed ID: 19650746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is left of the endoscopic antireflux devices?
    Jafri SM; Arora G; Triadafilopoulos G
    Curr Opin Gastroenterol; 2009 Jul; 25(4):352-7. PubMed ID: 19342950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapeutics for gastro-esophageal reflux symptoms.
    Zerbib F; Simon M
    Expert Rev Clin Pharmacol; 2012 Sep; 5(5):533-41. PubMed ID: 23121276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
    Higginbotham TW
    Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines.
    Haag S; Andrews JM; Katelaris PH; Gapasin J; Galmiche JP; Hunt R; Layer P; Malfertheiner P; Holtmann G
    Digestion; 2009; 80(4):226-34. PubMed ID: 19844107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy-resistant gastro-oesophageal reflux disease: endoluminal treatment not yet sufficiently compared with the gold standard, the laparoscopic Nissen fundoplication].
    Draaisma WA; Fegrachi S; Simmermacher RK; Broeders IA; Smout AJ; Gooszen HG
    Ned Tijdschr Geneeskd; 2008 Nov; 152(47):2553-8. PubMed ID: 19174936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New pharmacological agents for the treatment of gastroesophageal reflux disease.
    Vakil N
    Rev Gastroenterol Disord; 2008; 8(2):117-22. PubMed ID: 18641594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of an endoscopic suturing device (the "ESD") to treat patients with gastroesophageal reflux disease, after unsuccessful EndoCinch endoluminal gastroplication: another failure.
    Schiefke I; Neumann S; Zabel-Langhennig A; Moessner J; Caca K
    Endoscopy; 2005 Aug; 37(8):700-5. PubMed ID: 16032486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy.
    Miyamoto M; Haruma K; Takeuchi K; Kuwabara M
    J Gastroenterol Hepatol; 2008 May; 23(5):746-51. PubMed ID: 18028348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precise role of acid in non-erosive reflux disease.
    Wang C; Hunt RH
    Digestion; 2008; 78 Suppl 1():31-41. PubMed ID: 18832838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical therapy for gastroesophageal reflux disease in 2007.
    Katz PO
    Rev Gastroenterol Disord; 2007; 7(4):193-203. PubMed ID: 18192955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.